Traditional Chinese medicine formula for treating forgetting type mild cognitive impairment and preparation method

Abstract

The invention provides a traditional Chinese medicine formula for treating forgetting type mild cognitive impairment and a preparation method. The traditional Chinese medicine formula comprises the following substances in parts by mass: 5-15 parts of ginseng, 20-40 parts of polygonum multiflorum, 5-15 parts of pulp of fructus corni, 10-20 parts of Chinese yam, 10-20 parts of fructus alpiniae oxyphyllae, 20-40 parts of salviae miltiorrhizae, 5-15 parts of ligusticum wallichii, 5-15 parts of safflower carthamus, 10-20 parts of rhizoma acori graminei, 10-20 parts of polygala tenuifolia, 5-15 parts of curcuma aromatica, 5-15 parts of pericarpium citri reticulatae and 1-5 parts of borneol. The preparation method comprises the following steps: placing the ginseng, the polygonum multiflorum, thefructus corni, the Chinese yam, the fructus alpiniae oxyphyllae, the salviae miltiorrhizae, the ligusticum wallichii, the safflower carthamus, the rhizoma acori graminei, the polygala tenuifolia, thecurcuma aromatica, the pericarpium citri reticulatae and the borneol into a frying pan in proportion, adding water into the medicines, and decocting the medicines; and obtaining filtrate after decocting is completed, and orally taking the filtrate. The traditional Chinese medicine formula can be used for improving early diagnosis and treatment of patients with forgetting type mild cognitive impairment, has wide popularization and application value, and brings great social and economic benefits.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a traditional Chinese medicine formula and preparation method for amnestic mild cognitive impairment. Background technique [0002] Mild cognitive impairment (mild cognitive impairment, MCI) is a clinical syndrome with mild cognitive impairment in the elderly, mainly memory loss, but not enough to be diagnosed as dementia. A subtype with prominent memory impairment is called amnestic MCI (mildcognitive mpairment-amnestic, aMCI). Through the extensive and in-depth research on aMCI, the development of cognitive impairment can be improved or delayed, which is of positive significance to the improvement of the quality of life of the elderly population, and at the same time, it can be used for the early prevention of some Alzheimer's disease (Alzheimer disease, AD) and intervention provide a better entry point. So far, there are relatively few reports on Chinese medicine research...

AI Technical Summary

Problems solved by technology

Modern medicine has not yet fully understood the etiology and pathogenesis of amnestic mild cognitive impairment. Drugs are mainly used for symptomatic treatment, such as cholinesterase inhibitors, N-methyl D-aspartate receptor antagonists, and enhanced brain metabolism. Drugs, drugs metabolized by nutritional free radicals, etc. Although the above drugs have certain curative effects, they also have side effects to varying degrees and are not suitable for long-term use. However, effective prevention and treatment measures are still lacking.

Images